“In-Vitro Fertilization (IVF) Market To Reach $45.0 Billion By 2029 says Visiongain report”, says Visiongain
08 January 2020
Visiongain’s new report the In-Vitro Fertilization (IVF) Market Report: Forecasts by Instrument (Culture Media, Disposable Devices, Capital Equipment), by Treatment (Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen donor), by Application (Fertility Clinics, Hospitals, Others) plus analysis of leading companies operating in the global In-Vitro Fertilization market.
The global In-Vitro Fertilization market size was valued at $17.1 billion in 2019 and is expected to generate market revenue of $45.0 billion by the end of 2029 with a compound annual growth rate of 10.1%. Growing development of advanced technologies coupled with rising prevalence of infertility is expected to spur the market over the projected period. In-Vitro Fertilization is generally used to treat genetic problems or fertility. Supportive government regulations to encourage sperm freezing to stop chances of multiple pregnancies is projected to increase market concentration of In-Vitro Fertilization over the coming years. Additionally, technological advancement to enable pre identification of problems and diseases is expected to spur the market growth.
According to World Health Organization, One in every four couples in developing countries such as India, China, Brazil, Argentina, Peru, African countries, and Colombia had been found to be affected by infertility. Additionally, according to the American Society for Reproductive Medicine (ASRM), in 2018, infertility accounted for more than 7 million women in North America. Moreover, average age of marriage in developing as well as developed countries has increased over the past few years by virtue of increasing working population and increasing focus towards careers and the trends is expected to continue over the coming years.
Asia Pacific dominated overall In-Vitro Fertilization industry in 2018. Growing population, developing healthcare infrastructure in Malaysia, Indonesia, Singapore, and India is expected to prompted manufacturers to adopt plant expansion strategy. Moreover, availability of advanced technology in India, China, and Japan and low cost of treatment as compared to U.S. and European countries is expected to increase market reach over the coming years.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.